Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Prolactinoma 2Prolactin Deficiency, Isolated 1Hyperprolactinemia 1

Interventions

Cabergoline 5Dopamine Agonists 2ropinirole 1pasireotide 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Prolactinoma × Dopamine Agonists × Clear all
NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting
60 enrolled

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

NCT04107480 2020-07-20

PRolaCT - Three Prolactinoma RCTs

Leiden University Medical Center

Phase 4 Unknown
880 enrolled

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡